Abstract | DEFINITION:
Blackwater fever is a clinical entity characterized by acute intravascular hemolysis classically occuring after the re-introduction of quinine in long-term residents in Plasmodium falciparum endemic areas and repeatedly using the product. CLINICAL PROFILE: QUININE AND SIMILAR MOLECULES: Well known at the start of the 20th century, blackwater fever has become exceptional since 1950, when quinine was replaced by chloroquine. The disease reappeared in 1990, following the re-utilization of quinine because of resistance to chloroquine. Thereafter, several cases have been described with halofantrine and mefloquine, two new molecules similar to quinine (amino-alcohol family). The physiopathogenesis of the disease is not well known, however it would appear that the concomitance of a double sensitivization of the red blood cells to the P. falciparum red blood cells and to the amino-alcohols is necessary to provoke the hemolysis. EVOLUTION: The severity of the clinical picture often requires initial management in intensive care unit. Nowadays, however, prognosis is good and the disease usually regresses without after effects.
|
Authors | F Bruneel, B Gachot, M Wolff, J P Bedos, B Regnier, M Danis, F Vachon |
Journal | Presse medicale (Paris, France : 1983)
(Presse Med)
Vol. 31
Issue 28
Pg. 1329-34
(Sep 07 2002)
ISSN: 0755-4982 [Print] France |
Vernacular Title | Fièvre bilieuse hémoglobinurique. |
PMID | 12355996
(Publication Type: Comparative Study, English Abstract, Journal Article)
|
Chemical References |
- Antimalarials
- Drug Combinations
- Naphthoquinones
- Phenanthrenes
- atovaquone, proguanil drug combination
- fanasil, pyrimethamine drug combination
- Sulfadoxine
- Quinine
- halofantrine
- Proguanil
- Mefloquine
- Atovaquone
- Pyrimethamine
|
Topics |
- Adolescent
- Adult
- Aged
- Antimalarials
(adverse effects, therapeutic use)
- Atovaquone
- Blackwater Fever
(chemically induced, diagnosis, mortality, physiopathology, therapy)
- Critical Care
- Diagnosis, Differential
- Drug Combinations
- Humans
- Mefloquine
(adverse effects)
- Middle Aged
- Naphthoquinones
(therapeutic use)
- Phenanthrenes
(adverse effects)
- Prognosis
- Proguanil
(therapeutic use)
- Pyrimethamine
(therapeutic use)
- Quinine
(adverse effects)
- Sulfadoxine
(therapeutic use)
|